Clinical Trial Update: Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and safety of Biphasic Insulin Aspart 30 with Biphasic Human Insulin 30 on blood sugar control in subjects with Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Human Insulin 30 (biphasic human insulin 30)
• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-04-11